CCL3 and COVID-19: Huang et al. demonstrated that COVID-19 patients who required intensive care due to respiratory failure had higher plasma concentrations of IL-2, IL-7, IL-10, GCSF, IP-10, MCP-1, CCL-3 and TNF-α than non-intensive care patients [14].